The Efficacy of Tislelizumab Combined With Albumin-bound Paclitaxel and Platinum-based Chemotherapy in Patients With KRAS-mutated Lung Cancer

NCT07638878 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer (Locally Advanced or Metastatic)

Interventions

DRUG: tislelizumab in combination with nab-paclitaxel and platinum chemotherapy

Sponsor

Guangzhou Medical University